Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jikun PharmSci & Tech is a Shanghai-based biotechnology company specializing in AI-driven small molecule drug discovery. Founded by industry veterans with extensive experience in computational chemistry and pharmaceutical R&D, the company utilizes a proprietary platform that integrates physics-based modeling with deep learning. Jikun focuses on developing innovative therapeutics for challenging targets in oncology and immunology, aiming to significantly reduce the time and cost of early-stage drug development. The company's approach combines high-performance computing with experimental validation to optimize lead compounds with high precision. Jikun is currently advancing a pipeline of internal programs while exploring strategic collaborations within the life sciences industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jikun PharmSci & Tech.